查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1793483

多发性硬化症治疗设备的全球市场:类型·治疗设备·终端用户·各地区 (～2032年)

Global Multiple Sclerosis Treatment Devices Market Research Report by Type, by Treatment Devices, by End User, and by Region Forecast till 2032
出版日期: | 出版商: Market Research Future | 英文 165 Pages | 订单完成后即时交付

价格

预计到 2032 年，多发性硬化症治疗设备市场规模将从 8.1358 亿美元成长至 12.6387 亿美元。多发性硬化症治疗设备是指为帮助多发性硬化症患者解决肌肉无力、痉挛、平衡问题和慢性疼痛而开发的医疗器材。这些设备涵盖神经刺激器、机器人步态训练器和功能性电刺激 (FES) 系统。它们透过辅助活动和减轻症状来补充传统的药物治疗。

受疾病盛行率上升和辅助医疗技术创新的推动，全球多发性硬化症治疗设备市场正在稳步扩张。多发性硬化症影响中枢神经系统，在北美和欧洲最常见，加拿大报告的每 10 万人中约有 288 例。

最新的治疗设备正在改变患者护理，尤其是先进的神经刺激工具，例如脊髓刺激 (SCS)、经颅磁刺激 (TMS) 和可穿戴 FES 系统。这些设备使患者能够恢復行走能力、减少痉挛并缓解疼痛。近期的创新技术融合了人工智慧和基于感测器的监测技术，可根据患者的即时状况提供个人化治疗。智慧外骨骼、机器人步态训练器和嵌入感测器的纺织品正在为復健开闢新的可能性。

然而，在中低收入国家，市场仍面临课题。这些课题包括认知度低、诊断基础设施不足、昂贵。不过，医院、医疗器材公司和復健专业人员之间的策略合作伙伴关係正在填补这一空白。合作开发正在催生智慧 FES 矫正器、人工智慧驱动的疼痛缓解设备和远端监控平台，从而减少就诊次数并提高治疗依从性。随着持续的研究、投资和全球健康计画的推进，这些技术很可能在未来成为多发性硬化症管理的重要组成部分。

本报告研究了全球多发性硬化症治疗设备市场，并提供了市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场要素分析

  • 波特的五力分析
  • COVID-19对全球多发性硬化症治疗设备市场带来的影响

第5章 全球多发性硬化症治疗设备市场:各类型

  • 概要
  • 原发性进行性多发性硬化症 (PPMS)
  • 次发性进行性多发性硬化症 (SPMS)
  • 復髮型多发性硬化症 (RRMS)
  • 临床性孤发出症候群 (CIS)

第6章 全球多发性硬化症治疗设备市场:各治疗设备

  • 电刺激设备
    • 功能的电刺激 (FES)
    • 经皮电力神经刺激 (TENS)
  • 神经刺激设备
    • 脊髓刺激疗法 (SCS)
    • 脑深部刺激疗法 (DBS)

第7章 全球多发性硬化症治疗设备市场:各终端用户

  • 概要
  • 医院和诊所
  • 门诊病人手术中心

第8章 全球多发性硬化症治疗设备市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 俄罗斯
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 马来西亚
    • 泰国
    • 印尼
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中东·非洲
    • GCC各国
    • 南非
    • 其他

第9章 竞争情形

  • 市场占有率分析
  • 竞争仪表板
  • 上市公司的股票:摘要
  • 比较分析:主要企业的财务趋势
  • 主要的展开·成长策略

第10章 企业简介

  • ENOVIS
  • AXONICS, INC.
  • KONINKLIJKE PHILIPS N.V.
  • BTL
  • BAYER AG
  • MEDTRONIC
  • ABBOTT
  • BOSTON SCIENTIFIC CORPORATION
  • BIOTRONIK
  • SALUDA MEDICAL PTY LTD.

第11章 资料的引用

Product Code: MRFR/HC/57635-CR

Global Multiple Sclerosis Treatment Devices Market Research Report by Type [Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Relapsing-remitting Multiple Sclerosis (RRMS), Clinically Isolated Syndrome (CIS)], by Treatment Devices [Electrical Stimulation Devices (Functional Electrical Stimulation (FES), Transcutaneous Electrical Nerve Stimulation (TENS)), Neurostimulation Devices (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS))], by End User (Hospitals & Clinics, Ambulatory Surgical Centers), and by Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Forecast till 2032

Industry Overview

The multiple sclerosis treatment devices market stood at USD 813.58 million and is expected to grow to USD 1,263.87 million by 2032. MS treatment devices refer to medical equipment developed to assist people living with Multiple Sclerosis in coping with muscle weakness, spasticity, balance issues, and chronic pain. They range from neurostimulation devices to robotic gait trainers and functional electrical stimulation systems. By supporting mobility and reducing symptom severity, they complement traditional drug-based therapies.

The Global Multiple Sclerosis (MS) Treatment Devices market is expanding steadily, propelled by rising disease prevalence and innovation in assistive medical technologies. MS affects the central nervous system, with higher cases in North America and Europe. Canada has about 288 cases per 100,000 people.

Modern treatment devices are transforming patient care, particularly advanced neurostimulation tools like spinal cord stimulation (SCS), transcranial magnetic stimulation (TMS), and wearable functional electrical stimulation (FES) systems. These devices enable the patients to regain mobility, decrease spasticity, and alleviate pain. The recent innovations combine AI and sensor-based monitoring, which enable a patient to receive a custom-made therapy that changes according to his or her real-time condition. Smart exoskeletons, robotic-assisted gait trainers, and sensor-embedded textiles are coming up with new opportunities in rehabilitation.

However, still, there are still some barriers that the market is facing due to the conditions of low- and middle-income countries. These include limited awareness, a lack of enough diagnostic infrastructure, and affordability issues. On the other hand, strategic partnerships between hospitals, med-tech companies, and rehabilitation specialists are creating ways to cover this gap. Collaborations are resulting in the creation of smart FES braces, AI-powered pain relief devices, and remote monitoring platforms, which not only reduce hospital visits but also improve treatment compliance. Research, investment, and global health programs are continuing, and these technologies will likely be the main parts of MS management in the future.

Industry Segmentations

The global multiple sclerosis treatment devices market is classified based on the type, comprising primary progressive multiple sclerosis, secondary progressive multiple sclerosis, relapsing-remitting multiple sclerosis, and clinically isolated syndrome.

In terms of the treatment devices, the global market is segmented into electrical stimulation devices and neurostimulation devices. Functional electrical stimulation and transcutaneous electrical nerve stimulation are further segments of the ESD. Spinal cord stimulation and deep brain stimulation are parts of neurostimulation devices.

Based on the end users, the global multiple sclerosis treatment devices market is divided into hospitals & clinics, and ambulatory surgical centers.

Regional Analysis

Demand is largely shaped by consumer preference for premium and durable goods in the North American region. The upholstery sector in the U.S. automotive industry is the major volume driver, while luxury handbags and footwear brands are the main contributors to consumption of higher value. The growth in e-commerce has not only increased the scale but also the geographic scope of niche leather goods producers. Sustainability labeling is becoming a market differentiator.

Craftsmanship, quality, and sustainability are the first and foremost to European buyers. High-end fashion leather production in Italy and France reigns supreme, while Germany's automotive fleet demands precision-processed hides. Green certifications and traceable sourcing are key to market acceptance. Seasonal fashion cycles keep demand steady year-round.

Leather in APAC is required not only for the export of goods but also for the purpose of meeting the needs of growing domestic consumption. China's fashion and automotive markets are hot for mid-to-premium leather products. India balances large-scale export tanning with a rising domestic shoe industry. Technological upgrades in tanning processes are improving quality standards.

Durability and style have made leather the favorite of consumers, particularly in footwear and accessories. The domestic market of Brazil is in line with its export strength, while Argentina is still known for its premium craftsmanship. The shifts in the economy affect the buying power, but the exports hold steady owing to the competitive pricing.

The luxury retail sector in the Gulf states sustains high demand for imported premium leather goods. Africa's emerging middle class is slowly increasing domestic demand. Government incentives in countries like Ethiopia aim to grow local leather processing capacity. However, consumer preference still leans towards imported finished products.

Key Players

Key competitors in the global multiple sclerosis treatment devices market are Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd., Enovis, Bayer, Koninklijke Philips N.V., BTL, and Axonics Inc.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TYPE
  • 3.8 DATA MODELING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA MODELING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION
  • 3.10 INTRODUCTION
  • 3.11 DRIVERS
    • 3.11.1 INCREASING PREVALENCE OF MULTIPLE SCLEROSIS (MS)
    • 3.11.2 ADVANCEMENTS IN NEUROSTIMULATION AND WEARABLE DEVICES
  • 3.12 RESTRAINTS
    • 3.12.1 LIMITED AWARENESS AND ACCESSIBILITY IN DEVELOPING REGIONS
  • 3.13 OPPORTUNITY
    • 3.13.1 RISING COLLABORATIONS BETWEEN HEALTHCARE PROVIDERS AND TECHNOLOGY FIRMS

4 MARKET FACTOR ANALYSIS

  • 4.1 PORTER'S FIVE FORCES MODEL
    • 4.1.1 THREAT OF NEW ENTRANTS
    • 4.1.2 BARGAINING POWER OF SUPPLIERS
    • 4.1.3 THREAT OF SUBSTITUTES
    • 4.1.4 BARGAINING POWER OF BUYERS
    • 4.1.5 INTENSITY OF RIVALRY
  • 4.2 IMPACT OF COVID-19 ON THE GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET

5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE

  • 5.1 OVERVIEW
  • 5.2 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS)
  • 5.3 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS)
  • 5.4 RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
  • 5.5 CLINICALLY ISOLATED SYNDROME (CIS)

6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES

  • 6.1 INTRODUCTION
  • 6.2 ELECTRICAL STIMULATION DEVICES
    • 6.2.1 FUNCTIONAL ELECTRICAL STIMULATION (FES)
    • 6.2.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
  • 6.3 NEUROSTIMULATION DEVICES
    • 6.3.1 SPINAL CORD STIMULATION (SCS)
    • 6.3.2 DEEP BRAIN STIMULATION (DBS)

7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 HOSPITALS & CLINICS
  • 7.3 AMBULATORY SURGICAL CENTERS

8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET BY REGION

  • 8.1 OVERVIEW
  • 8.2 NORTH AMERICA
    • 8.2.1 US
    • 8.2.2 CANADA
  • 8.3 EUROPE
    • 8.3.1 GERMANY
    • 8.3.2 FRANCE
    • 8.3.3 UK
    • 8.3.4 SPAIN
    • 8.3.5 ITALY
    • 8.3.6 RUSSIA
    • 8.3.7 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 INDIA
    • 8.4.3 JAPAN
    • 8.4.4 SOUTH KOREA
    • 8.4.5 MALAYSIA
    • 8.4.6 THAILAND
    • 8.4.7 INDONESIA
    • 8.4.8 REST OF ASIA PACIFIC
  • 8.5 SOUTH AMERICA
    • 8.5.1 BRAZIL
    • 8.5.2 MEXICO
    • 8.5.3 ARGENTINA
    • 8.5.4 REST OF SOUTH AMERICA
  • 8.6 MIDDLE EAST AND AFRICA
    • 8.6.1 GCC COUNTRIES
    • 8.6.2 SOUTH AFRICA
    • 8.6.3 REST OF MEA

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS, 2023
  • 9.3 COMPETITOR DASHBOARD
  • 9.4 PUBLIC PLAYERS STOCK SUMMARY
  • 9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
  • 9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.1.1 PRODUCT LAUNCH
    • 9.1.2 PRODUCT APPROVAL

10 COMPANY PROFILES

  • 10.1 ENOVIS
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 AXONICS, INC.
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 KEY STRATEGIES
  • 10.3 KONINKLIJKE PHILIPS N.V.
    • 10.3.1 COMPANY OVERVIEW
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 SWOT ANALYSIS
    • 10.3.6 KEY STRATEGIES
  • 10.4 BTL
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 KEY STRATEGIES
  • 10.5 BAYER AG
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 KEY STRATEGY
  • 10.6 MEDTRONIC
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 SWOT ANALYSIS
    • 10.6.6 KEY STRATEGIES
  • 10.7 ABBOTT
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 BOSTON SCIENTIFIC CORPORATION
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 KEY STRATEGIES
  • 10.9 BIOTRONIK
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 KEY STRATEGIES
  • 10.10 SALUDA MEDICAL PTY LTD.
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 KEY STRATEGIES

11 DATA CITATIONS

  • 11.1 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR CLINICALLY ISOLATED SYNDROME (CIS), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR FUNCTIONAL ELECTRICAL STIMULATION (FES), BY REGION,2019-2032 (USD MILLION) REGION
  • TABLE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS), BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY REGION, 2019-2032 (USD MILLION) 56 REGION
  • TABLE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SPINAL CORD STIMULATION (SCS), BY REGION, 2019-2032 (USD MILLION) 57 REGION
  • TABLE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR DEEP BRAIN STIMULATION (DBS), BY REGION, 2019-2032 (USD MILLION) 58 REGION
  • TABLE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION) 60 REGION
  • TABLE 18 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION) 61 REGION
  • TABLE 19 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 20 NORT AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 21 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 23 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 26 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 27 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 28 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 29 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 30 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 31 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 32 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 33 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 34 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 35 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 36 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 37 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 38 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 39 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 40 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 41 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 42 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 44 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 45 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 46 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 47 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 48 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 49 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 50 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 51 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 52 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 53 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 54 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 55 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 56 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 57 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 58 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 59 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 60 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 61 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 62 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 63 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 64 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 65 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 66 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 67 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 68 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 69 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 70 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 71 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 72 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 73 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)
  • TABLE 74 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
  • TABLE 75 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 76 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 77 ASIA PACIFIC MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 83 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 84 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 85 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 86 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 87 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 88 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 89 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 90 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
  • TABLE 91 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 92 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 93 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 94 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 95 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 96 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 - 2032 (USD MILLION)
  • TABLE 97 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 98 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 99 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 100 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 101 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 102 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 103 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 104 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 105 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 106 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
  • TABLE 107 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 108 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 109 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 110 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 111 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
  • TABLE 112 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 113 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 114 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 115 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 116 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,
  • TABLE 117 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 118 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 119 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 120 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 121 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 122 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 123 SOUTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 124 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 125 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 126 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 127 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 128 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 129 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 130 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 131 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 132 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
  • TABLE 133 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 134 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 135 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 136 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 137 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 2032 (USD MILLION)
  • TABLE 138 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 139 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 140 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 141 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 142 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 143 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 144 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 145 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 146 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 147 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 148 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 149 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 150 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 151 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 152 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 153 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 154 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 157 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 158 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 159 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 160 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 161 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 162 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 163 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 164 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 165 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 166 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019-2032 (USD MILLION)
  • TABLE 167 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 168 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 169 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 170 PRODUCT LAUNCH
  • TABLE 171 PRODUCT APPROVAL
  • TABLE 172 ENOVIS: PRODUCTS OFFERED
  • TABLE 173 AXONICS, INC.: PRODUCTS OFFERED
  • TABLE 174 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 175 BTL: PRODUCT OFFERED
  • TABLE 176 BAYER AG: PRODUCTS OFFERED
  • TABLE 177 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 178 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 179 ABBOTT: PRODUCTS OFFERED
  • TABLE 180 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 181 ABBOTT: KEY DEVELOPMENTS
  • TABLE 182 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 183 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: STRUCTURE
  • FIGURE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2022-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET
  • FIGURE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
  • FIGURE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TYPE, 2023
  • FIGURE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TREATMENT DEVICES SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2023 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TREATMENT DEVICES, 2023
  • FIGURE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; END USER SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2023 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY END USER, 2023
  • FIGURE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2023 & 2032 (USD MILLION)
  • FIGURE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY REGION, 2023
  • FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 18 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 19 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2023
  • FIGURE 20 EUROPE MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 22 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2023
  • FIGURE 23 ASIA PACIFIC MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 25 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)
  • FIGURE 27 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 28 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 29 MIDDLE EAST AND AFRICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)
  • FIGURE 30 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
  • FIGURE 31 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%)
  • FIGURE 32 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023
  • FIGURE 33 COMPETITOR DASHBOARD: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET
  • FIGURE 34 ENOVIS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 35 ENOVIS: SWOT ANALYSIS
  • FIGURE 36 AXONICS, INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS
  • FIGURE 39 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 42 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 ABBOTT: SWOT ANALYSIS
  • FIGURE 44 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT